170 results found
Definition of Recorded and Rendered – Digital creative works; what you need to submit when reporting your Recorded and Rendered – Digital creative work NTROs for the annual Sydney Research Collection and ERA; tips and tools to help you with reporting your research outputs in the form of Recorded and Rendered – Digital creative work.
Definition of Research report for an external body; what you need to submit when reporting Research report for an external body NTROs for the annual Sydney Research Collection and ERA; tips and tools to help you with reporting your research outputs in the form of a Research report for an external body.
Researchers are often entrusted with sensitive information which if managed incorrectly could have serious implications for the researcher, their research subjects, and/or the University.
This article outlines how researchers and research support staff can use the Research Professional online database to discover local and international funding opportunities, research policies and research practice news across a broad range of disciplines. Specifically, the article will highlight general features of the database, specialised roles, role capabilities, and reference materials that users can access to better utilise the platform.
When using the eNotebook, knowing about certain features and practices can enhance your experience and help you manage your research data more easily.
Research content for a Non-Traditional Research Output (NTRO) is often not apparent in the output itself. A Research Statement demonstrates that your NTRO meets both the definition of research and the criteria for the specific type of NTRO. You will need to provide a research statement when reporting most types of NTROs.
This article provides an overview of the IRMA-ORCID system integration project, and benefits of registering for an ORCID profile.
The University’s Integrated Research Management Application (IRMA) captures publication data, research grants and contracts, and human and animal ethics applications.
The Research Portfolio and ICT have implemented a system integration between IRMA and ORCID to enable automated updates of research outputs to researcher ORCID profiles.
The project has also incorporated development of BibTex export functionality from IRMA, enabling more streamlined export of publication data not included in the integration.
Project information and support ORCID identifier: Enhancing your global presence
The NHMRC Synergy Grants support outstanding multidisciplinary teams of investigators to work together to answer major questions that cannot be answered by a single investigator.
This article outlines the procedures for applying for a NSW Authority to Possess or Supply Schedule 8 or Schedule 9 substances, Prohibited Drugs/Plants for the Purpose of Research, Instruction, Analysis or Treatment of Animals.
You must hold or be listed as an authorised user on an authority issued through NSW Health Pharmaceutical Services to work with Schedule 8 or 9 drugs.
Information on Importing or Exporting scheduled drugs is included below.
Schedule 8 and 9 Drugs being used in Clinical Trials require different forms and governance processes, please contact clinical-trials.research@sydney.edu.au for advice.
For any queries in relation to schedule drug processes and procedures, including work occurring outside NSW, please contact: scheduled.drugs@sydney.edu.au
The expectations for working with scheduled drugs at the University can be found in the Management of drugs in laboratory and animal-based research procedures 2024.
This article provides an overview of the process of setting up academic staff profiles (aka author profile or user account) and capturing TRO’s and NTRO’s in IRMA.
Confidentiality Agreement (self-service) webform allows the auto-generation of a simple, fair contract for the exchange of low risk confidential information (excluding research data) with one other organisation for a nominated purpose.
The Authority To Submit (ATS) facilitates written confirmation of Faculty support for a research grant to be submitted from relevant delegates who have authority for financial and other resource allocation. An ATS is required for all research grants that a University of Sydney staff member is named on. This includes applications that will not be administered by the University of Sydney (non-lead applications), as well as applications that will be administered by the University of Sydney (lead applications). The ATS, with all required approvals, must be completed before the application can be submitted to the funder.
A digital version of the old ATS form is implemented in ServiceNow with an automated workflow to collect approvals and document the process under an overarching Funding submission record. This article aims to assist researchers in submitting the form.
Note: the digital ATS will only be required for the grant opportunities listed below. For all other opportunities, the paper-based form (pdf) will be required.
This article aims to provide answers to some commonly asked questions about the IRMA-ORCID Integration.
IRMA-ORCID integration processes
Managing your ORCID profile
Project information and support ORCID identifier: Enhancing your global presence
The University implementation is scheduled for roll-out in June 2022.
Support documentation will be updated as the functionality is fully implemented.
This article has been superseded. Please see sydney.edu.au/research-data-platforms
This article outlines the procedures for disposal of empty or partial containers of scheduled drugs used in laboratory or animal based research.
Expired, contaminated or unwanted drugs should be disposed of in a timely manner.
Schedule 4D, Schedule 8 and Schedule 9 drugs have strict requirements for destruction and must be disposed of following the process below.
All drugs, including dilutions and small amounts remaining from procedures, must be disposed of safely and should never be tipped down the sink.
Clinical trial drugs should follow their validated disposal process when it is included in one of the clinical trial’s essential documents e.g. protocol, otherwise requests to dispose of drugs can be submitted via the Clinical medicine disposal process. Researchers should maintain records that document the system for disposal and the destruction of the product/s.
For any queries in relation to schedule drug processes and procedures, or disposal/destruction advice for other facilities/campuses, please contact: scheduled.drugs@sydney.edu.au
Research data is a valuable resource that needs to be managed optimally to ensure its integrity and security, to realise its collaborative potential, and to meet legislative and policy requirements.
The NHMRC Investigator Grants consolidate separate fellowship and research support into one grant scheme that provides the highest-performing researchers at all career stages with funding for their salary (if required) and a significant research support package.
These grants provide the investigator with flexibility to pursue important new research directions as they arise and to form collaborations as needed, rather than being restricted to the scope of a specific research project.
Clinical trial medications should follow their validated disposal process when it is included in one of the clinical trial’s essential documents e.g. protocol, otherwise requests to dispose of drugs can be submitted via the processes outlined below.
Researchers should maintain records that document the system for disposal and the destruction of the product/s.
For items that require a destruction certificate, a work request must first be raised in CampusAssist to obtain a quote.
Bulk University Health Clinic* medications should be disposed of via the University hazardous waste program (Schedule 2, 3, 4) following this process. For indivdual or a small number of barcoded containers (eg < 10), please contact your local TSS Technical Officer.
If a disposal request involves S4D, S8 or S9 products, please email scheduled.drugs@sydney.edu.au before completing any processes.
*Clinics as per the definition in the Health Clinics and Clinical Services Policy 2020
This article outlines the procedures for transporting high risk scheduled drugs: Schedule 4D (S4D), Schedule 8 (S8) and Schedule 9 (S9).
If S4D, S8 or S9 drugs are stolen or lost (including spills and breakages), the reporting process must immediately be followed.
All drugs and medicines need to be managed to prevent access to non authorised users.
Transport of any drug/medication should follow the principles of this guide.
For any queries in relation to schedule drug processes and procedures, please contact: scheduled.drugs@sydney.edu.au
To ensure your NTRO will be eligible for inclusion in the annual Sydney Research Collection and in the University’s ERA submission, as well as counting towards your annual academic performance, it pays to plan ahead for the publication of your NTRO.
Pages: